Storys aus Parma

Filtern
  • 30.01.2023 – 08:01

    Chiesi Farmaceutici S.p.A.

    Chiesi appoints Giuseppe Accogli as new Group CEO

    Parma, Italy (ots/PRNewswire) - - Giuseppe Accogli is a successful Executive Leader with 25 years of international experience in the Med-tech sector of reputed and complex companies such as Tyco Healthcare (Covidien), Baxter and Medtronic - "As CEO, I strive to enable our leaders, people and partners to achieve even greater success in fulfilling the commitment to be a sustainable force for good in the biopharmaceutical ...

  • 22.09.2022 – 09:01

    Chiesi Farmaceutici S.p.A.

    Chiesi is recertified as a B Corp and sets new tougher objectives for action by 2025

    Parma, Italy (ots/PRNewswire) - - The Group has increased its B-Impact score by 16.3 points, with 103.8 out of 200 compared to its first certification in 2019; - The recertification process by B Lab identifies further focus for action and continuous improvement. The B Corp movement, established to help companies balance profit with purpose, is growing by the day. Today ...

  • 01.04.2022 – 09:00

    Chiesi Farmaceutici S.p.A.

    CHIESI GROUP CONTINUES GROWTH

    Parma, Italy (ots/PRNewswire) - - 2021 Turnover €2.42bn - up 8.6% - Internationally China up 22%, US up >10% - Continued focus on innovation: almost 20% of turnover invested in R&D - Chiesi recognised as Top Employer in eight markets and as Top Employer Europe for 10th consecutive year Growth continues at Chiesi, the international research-focussed pharmaceutical group and its 30 global affiliates with turnover at €2.42bn, up 8.6% vs 2020. Gross operating profit (EBITDA) ...

  • 13.09.2021 – 07:00

    Chiesi Group

    Climate Change Major Threat To Respiratory Health

    Parma, Italy (ots/PRNewswire) - Produced by the Economist Intelligence Unit and commissioned by Chiesi Group, a new report Climate change and its impact on lung health: a focus on Europe says climate change is damaging respiratory health in ways not commonly known.i In Europe, climate change disproportionately affects the vulnerable, those with underlying health conditions and the economically disadvantagedi. The report ...

  • 10.05.2021 – 10:00

    Chiesi Group

    Chiesi Group calls for #ActionOverWords in climate change fight

    Parma, Italy (ots/PRNewswire) - Chiesi Group is calling for #ActionOverWords to encourage measurable sustainability action and invite accountability. Announcing its 2035 carbon neutral target, Chiesi is not the first company to make public commitments to reduce its carbon footprint, but wants to start a conversation about corporate action: the need to move from ...

  • 23.02.2015 – 13:15

    Holostem Terapie Avanzate - Centro di Medicina Rigenerativa "Stefano Ferrari" - Chiesi Farmaceutici S.p.A.

    Europe Approves Holoclar®, the First Stem Cell-Based Medicinal Product

    Parma And Modena, Italy (ots/PRNewswire) - The collaboration between a public excellent research center and a solid private pharmaceutical company allowed to achieve an extraordinary result, entirely "made in Italy": the first medicinal product containing stem cells approved in the Western world The European Commission has granted a conditional marketing authorization, ...